Proapoptotic PUMA targets stem-like breast cancer cells to suppress metastasis

Area of Science:

• Oncology
• Cancer Stem Cell Biology
• Molecular Oncology

Background:

• Breast cancer metastasis is driven by cells with stem cell properties.
• Targeting these aggressive cells remains a challenge in human cancers.
• Identifying vulnerabilities of cancer stem cells is crucial for effective treatment.

Purpose of the Study:

• To identify and characterize rare stem-like cells in human breast tumors.
• To elucidate the molecular mechanisms regulating stemness and PUMA expression in these cells.
• To explore therapeutic strategies targeting these cells by modulating PUMA levels.

Main Methods:

• Identification of rare stem-like cells based on low p53-upregulated modulator of apoptosis (PUMA) expression.
• Analysis of the integrin αvβ3/Src/Slug signaling axis in regulating PUMA.
• Genetic and pharmacological inhibition of αvβ3/Src signaling.
• Assessment of PUMA expression, apoptosis sensitivity, and pulmonary metastasis.

Main Results:

• Rare stem-like breast cancer cells exhibit low PUMA levels and drive tumor progression independently of subtype.
• The integrin αvβ3/Src/Slug axis suppresses PUMA, promoting tumor stemness.
• Disruption of αvβ3/Src signaling upregulates PUMA, depletes stem-like cells, and reduces metastasis.
• Targeting this pathway did not affect primary tumor growth.

Conclusions:

• PUMA is a critical vulnerability in stem-like breast cancer cells.
• Pharmacological inhibition of Src to upregulate PUMA offers a potential strategy to selectively target aggressive breast cancers.
• This approach may reduce metastasis without impacting primary tumor growth.